title: A new fractioning process to decrease the price of ranibizumab.
authors.forename: Miguel
authors.initials: M
authors.lastname: González-Andrades
authors.forename: José Ignacio
authors.initials: JI
authors.lastname: Muñoz-Ávila
authors.forename: Catalina
authors.initials: C
authors.lastname: Medarde-Caballero
authors.forename: Cristina
authors.initials: C
authors.lastname: Fernández-López
authors.forename: Miguel
authors.initials: M
authors.lastname: Damas-Alonso
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000191:economics*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000191:economics*; D004339:Drug Compounding / Q000191:economics*; D016527:Drug Costs; D005128:Eye Diseases / Q000188:drug therapy; D006801:Humans; D058449:Intravitreal Injections; D004364:Pharmaceutical Preparations / Q000191:economics*; D000069579:Ranibizumab
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D004364:Pharmaceutical Preparations; D000069579:Ranibizumab